GERN logo
GERN NASDAQ US

Geron Corporation - Common Stock

Healthcare · Biotechnology Website · IPO Jul 1996
$1.66
▲ +$0.00 (+0.00%)
Vol 33.6M
6
Quality Score
fail
Mkt Cap
$842.6M
ROE
-30.2%
Margin
-43.4%
D/E
99.96
Beta
0.63
52W
$1–$4

Wall Street Consensus

13 analysts · Apr 2026
4
Strong Buy
5
Buy
3
Hold
1
Sell
0
Strong Sell
69.2%
Buy Rating

Price Chart

Similar Stocks

NVAX
Novavax Inc
P/E 3.2
$1.1B
CRVS
Corvus Pharmaceuticals Inc
$575.1M
SVRA
Savara Inc
$1.2B
AVBP
ArriVent BioPharma Inc
$830.6M
KALV
Kalvista Pharmaceuticals Inc
$816.3M
CTMX
CytomX Therapeutics Inc
P/E 25.8
$721.8M
CMPX
Compass Therapeutics Inc.
$955.1M
AKTS
Aktis Oncology Inc

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.03 $-0.02 +$0.01
Sep 2025 $-0.03 $-0.03 +$0.00
Jun 2025 $-0.03 $-0.02 +$0.01
Mar 2025 $-0.04 $-0.03 +$0.01

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -31.7% -32.0% -32.0% -32.0% -30.1% -30.1%
P/E (TTM) — — — — — —
Net Margin -33.4% -53.5% -53.5% -53.5% -43.4% -43.4%
Gross Margin 97.6% 97.8% 97.8% 97.8% 97.7% 97.7%
D/E Ratio 95.16 45.85 45.85 45.85 47.95 99.96
Current Ratio 7.87 7.87 7.87 7.87 5.96 5.96

Key Ratios

ROA (TTM)
-14.0%
P/S (TTM)
4.59
P/B
7.6
EPS (TTM)
$-0.12
CF/Share
$-0.34
Rev Growth 3Y
+281.2%
52W High
$3.68
52W Low
$1.04
$1.04 52-Week Range $3.68

How does GERN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

GERN AAPG ABEO ABOS ABP

GERN valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
4.6
▼ 64% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
7.6
▲ 210% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

GERN profitability vs Biotechnology peers

ROE
-30.2%
▲ 55% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-43.4%
▲ 85% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
97.7%
▲ 24% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-14.0%
▲ 70% above peers (-46.7%)
vs Peers
vs Industry
Top tier

GERN financial health vs Biotechnology peers

D/E ratio
100.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
6.0
▲ 34% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
0.6
▼ 35% below peers (1.0)
vs Peers
vs Industry
More volatile

GERN fundamentals radar

GERN Peer median Industry

GERN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

GERN vs peers: key metrics

Latest News

No related news yet